Skip to main content
Erschienen in: Lung 2/2011

01.04.2011

Bronchoalveolar Lavage and Other Methods to Define the Human Respiratory Tract Milieu in Health and Disease

verfasst von: Herbert Y. Reynolds

Erschienen in: Lung | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

During fiber-optic bronchoscopy (FOB), surface sampling of the human respiratory airways and alveolar unit can be done with bronchoalveolar lavage (BAL), plus selective sites can be brushed for cells and transbronchial biopsies made in adjacent tissue. This permits analysis of the respiratory tract’s milieu in healthy normals, in those with disease, and in control subjects. These combined procedures have been an established approach for obtaining specimens for research and for clinical assessment for over four decades. However, now new less invasive sampling methods are emerging. This review emphasizes BAL and the cellular and noncellular components recovered in fluid that have contributed to improving knowledge of how the respiratory tree’s innate immunity can protect, and how airway structures can become deranged and manifest disease. After a discussion of training for FOB and procedural issues, a spectrum of respiratory diseases studied with BAL is presented, including airway illness (asthma and chronic obstructive pulmonary disease), diffuse interstitial lung diseases [idiopathic pulmonary fibrosis, rheumatoid interstitial lung disease (ILD), granulomatous ILDs], lung infections, lung malignancy, and upper and lower tract airway problems. Some recent studies with exhaled breath condensate analyses are given.
Literatur
1.
Zurück zum Zitat Simmons JG (2002) Hippocrates: rational medicine (460–370 B.C.). In: Doctors and discoveries: lives that created today’s medicine. Houghton Mifflin, Boston, pp 29–33 Simmons JG (2002) Hippocrates: rational medicine (460–370 B.C.). In: Doctors and discoveries: lives that created today’s medicine. Houghton Mifflin, Boston, pp 29–33
2.
Zurück zum Zitat Simmons JG (2002) Claude Bernard (1813–1878)—Medicine and modern experimental physiology. In: Doctors and discoveries: lives that created today’s medicine. Houghton Mifflin, Boston, pp 14–17 Simmons JG (2002) Claude Bernard (1813–1878)—Medicine and modern experimental physiology. In: Doctors and discoveries: lives that created today’s medicine. Houghton Mifflin, Boston, pp 14–17
3.
Zurück zum Zitat Reynolds HY (2004) President’s address: R.T.H. Laënnec, M.D.—clinicopathologic observations, using the stethoscope, made chest medicine more scientific. Trans Am Clin Climatol Assoc 115:1–29PubMed Reynolds HY (2004) President’s address: R.T.H. Laënnec, M.D.—clinicopathologic observations, using the stethoscope, made chest medicine more scientific. Trans Am Clin Climatol Assoc 115:1–29PubMed
4.
Zurück zum Zitat Reynolds HY (1987) Bronchoalveolar lavage: state of art. Am Rev Respir Dis 135:250–263PubMed Reynolds HY (1987) Bronchoalveolar lavage: state of art. Am Rev Respir Dis 135:250–263PubMed
5.
Zurück zum Zitat Reynolds HY (2000) Use of bronchoalveolar lavage in humans—past necessity and future imperative. Lung 178:271–293PubMedCrossRef Reynolds HY (2000) Use of bronchoalveolar lavage in humans—past necessity and future imperative. Lung 178:271–293PubMedCrossRef
6.
Zurück zum Zitat Rottoli P, Bargagli E, Landi C, Magi B (2009) Proteomic analysis in interstitial lung diseases: a review. Curr Opin Pulm Med 15:470–478PubMedCrossRef Rottoli P, Bargagli E, Landi C, Magi B (2009) Proteomic analysis in interstitial lung diseases: a review. Curr Opin Pulm Med 15:470–478PubMedCrossRef
7.
Zurück zum Zitat Reynolds HY (2001) Sampling local respiratory tract sites for inflammation. Sarcoidosis Vasc Diffuse Lung Dis 18:138–148PubMed Reynolds HY (2001) Sampling local respiratory tract sites for inflammation. Sarcoidosis Vasc Diffuse Lung Dis 18:138–148PubMed
8.
Zurück zum Zitat Reynolds HY, Newball HH (1974) Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med 84:559–573PubMed Reynolds HY, Newball HH (1974) Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med 84:559–573PubMed
9.
Zurück zum Zitat Busse WW, Wanner A, Adams K, Reynolds HY, Castro M, Chowdhury B, Kraft M, Levine RJ, Peters SP, Sullivan EJ (2005) NHLBI/NIAID workshop: investigative bronchoprovocation and bronchoscopy in airway diseases. Am J Respir Crit Care Med 172:807–816PubMedCrossRef Busse WW, Wanner A, Adams K, Reynolds HY, Castro M, Chowdhury B, Kraft M, Levine RJ, Peters SP, Sullivan EJ (2005) NHLBI/NIAID workshop: investigative bronchoprovocation and bronchoscopy in airway diseases. Am J Respir Crit Care Med 172:807–816PubMedCrossRef
10.
Zurück zum Zitat Kazmierowski JA, Fauci AS, Reynolds HY (1976) Characterization of lymphocytes in bronchial lavage fluid from monkeys. J Immunol 116:615–618PubMed Kazmierowski JA, Fauci AS, Reynolds HY (1976) Characterization of lymphocytes in bronchial lavage fluid from monkeys. J Immunol 116:615–618PubMed
11.
Zurück zum Zitat Reynolds HY (2008) Bronchoalveolar lavage-obtaining biological specimens from the respiratory tract surface. Sarcoidosis Vasc Diff Lung Dis 25:5–9 Reynolds HY (2008) Bronchoalveolar lavage-obtaining biological specimens from the respiratory tract surface. Sarcoidosis Vasc Diff Lung Dis 25:5–9
12.
Zurück zum Zitat Silvestri GA (2008) The evolution of bronchoscopy training (editorial). Respiration 76:19–20PubMedCrossRef Silvestri GA (2008) The evolution of bronchoscopy training (editorial). Respiration 76:19–20PubMedCrossRef
13.
Zurück zum Zitat Wahidi MM, Silvestri GA, Coakley RD, Ferguson JS, Shepherd RW, Moses L, Confori J, Que LG, Anstrom KJ, McGuire F, Colt H, Downie GH (2010) A prospective multi-center study of competency metrics and educational interventions in the learning of bronchoscopy among starting pulmonary fellows. Chest 137:1040–1049PubMedCrossRef Wahidi MM, Silvestri GA, Coakley RD, Ferguson JS, Shepherd RW, Moses L, Confori J, Que LG, Anstrom KJ, McGuire F, Colt H, Downie GH (2010) A prospective multi-center study of competency metrics and educational interventions in the learning of bronchoscopy among starting pulmonary fellows. Chest 137:1040–1049PubMedCrossRef
14.
Zurück zum Zitat Yoneda KY, Morrissey BM (2008) The technique of adult flexible bronchoscopy: part 1. J Respir Dis 29:423–428 Yoneda KY, Morrissey BM (2008) The technique of adult flexible bronchoscopy: part 1. J Respir Dis 29:423–428
15.
Zurück zum Zitat Buckley JD, Addrizzo-Harris DJ, Clay AS, Curtis JR, Kotloff RM, Lorin SM, Murin S, Sessler CN, Rogers PL, Rosen MJ, Spevetz A, King TE, Malhotra A, Parsons PE (2009) Multisociety task force recommendations of competencies in pulmonary and critical care medicine. Am J Respir Crit Care Med 180:290–295PubMedCrossRef Buckley JD, Addrizzo-Harris DJ, Clay AS, Curtis JR, Kotloff RM, Lorin SM, Murin S, Sessler CN, Rogers PL, Rosen MJ, Spevetz A, King TE, Malhotra A, Parsons PE (2009) Multisociety task force recommendations of competencies in pulmonary and critical care medicine. Am J Respir Crit Care Med 180:290–295PubMedCrossRef
16.
Zurück zum Zitat Silvestri GA, Vincent BD, Wahidi MM, Robinette E, Hansbrough JR, Downie GH (2009) A phase 3, randomized, double-blind study to access the efficacy and safety of fospropofol disodium injection for moderate sedation in patients undergoing flexible bronchoscopy. Chest 135:41–47PubMedCrossRef Silvestri GA, Vincent BD, Wahidi MM, Robinette E, Hansbrough JR, Downie GH (2009) A phase 3, randomized, double-blind study to access the efficacy and safety of fospropofol disodium injection for moderate sedation in patients undergoing flexible bronchoscopy. Chest 135:41–47PubMedCrossRef
17.
Zurück zum Zitat Baughman RP (2007) Technical aspects of bronchoalveolar lavage: recommendations for a standard procedure. Semin Respir Crit Care Med 28:475–485PubMedCrossRef Baughman RP (2007) Technical aspects of bronchoalveolar lavage: recommendations for a standard procedure. Semin Respir Crit Care Med 28:475–485PubMedCrossRef
18.
Zurück zum Zitat Meyer KC (2007) Bronchoalveolar lavage as a diagnostic tool. Semin Respir Crit Care Med 28:546–560PubMedCrossRef Meyer KC (2007) Bronchoalveolar lavage as a diagnostic tool. Semin Respir Crit Care Med 28:546–560PubMedCrossRef
19.
Zurück zum Zitat Rankin JA, Snyder PE, Schachter EN, Matthay RA (1984) Bronchoalveolar lavage. Its safety in subjects with mild asthma. Chest 85:723–728PubMedCrossRef Rankin JA, Snyder PE, Schachter EN, Matthay RA (1984) Bronchoalveolar lavage. Its safety in subjects with mild asthma. Chest 85:723–728PubMedCrossRef
20.
Zurück zum Zitat Metzger WJ, Richerson HB, Worden K, Monick M, Hunninghake GW (1986) Bronchoalveolar lavage of allergic asthmatic patients following allergen bronchoprovocation. Chest 89:477–483PubMedCrossRef Metzger WJ, Richerson HB, Worden K, Monick M, Hunninghake GW (1986) Bronchoalveolar lavage of allergic asthmatic patients following allergen bronchoprovocation. Chest 89:477–483PubMedCrossRef
21.
Zurück zum Zitat Metzger WJ, Nugent K, Richerson HB, Moseley P, Lakin R, Zavala D, Hunninghake GW (1985) Methods for bronchoalveolar lavage in asthmatic patients following bronchoprovocation and local antigen challenge. Chest 87(Suppl):16S–19SPubMedCrossRef Metzger WJ, Nugent K, Richerson HB, Moseley P, Lakin R, Zavala D, Hunninghake GW (1985) Methods for bronchoalveolar lavage in asthmatic patients following bronchoprovocation and local antigen challenge. Chest 87(Suppl):16S–19SPubMedCrossRef
22.
Zurück zum Zitat Bernstein IL, Boushey HA, Cherniack RM, other Workshop Participants (1985) NHLBI Workshop summary and recommendations of a workshop on the investigative use of fiberoptic bronchoscopy and bronchoalveolar lavage in asthmatics. Am Rev Respir Dis 132:180–182 Bernstein IL, Boushey HA, Cherniack RM, other Workshop Participants (1985) NHLBI Workshop summary and recommendations of a workshop on the investigative use of fiberoptic bronchoscopy and bronchoalveolar lavage in asthmatics. Am Rev Respir Dis 132:180–182
23.
Zurück zum Zitat Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A, Koth LL, Arron JR, Fahy JV (2009) T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 180:388–395PubMedCrossRef Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A, Koth LL, Arron JR, Fahy JV (2009) T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 180:388–395PubMedCrossRef
24.
Zurück zum Zitat Thunberg S, Gafvelin G, Nord M, Grönneberg R, Grunewald J, Eklund A, van Hage M (2010) Allergen provocation increases Th2-cytokines and FOXP3 expression in the asthmatic lung. Allergy 65:311–318PubMedCrossRef Thunberg S, Gafvelin G, Nord M, Grönneberg R, Grunewald J, Eklund A, van Hage M (2010) Allergen provocation increases Th2-cytokines and FOXP3 expression in the asthmatic lung. Allergy 65:311–318PubMedCrossRef
25.
Zurück zum Zitat Punturieri A, Croxton TL, Weinmann G, Kiley JP (2007) The changing face of COPD (editorial). Am Fam Physician 75:315–316PubMed Punturieri A, Croxton TL, Weinmann G, Kiley JP (2007) The changing face of COPD (editorial). Am Fam Physician 75:315–316PubMed
26.
Zurück zum Zitat Turner MC, Chen Y, Krewski D, Calle EE, Thun MJ (2007) Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med 176:285–290PubMedCrossRef Turner MC, Chen Y, Krewski D, Calle EE, Thun MJ (2007) Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med 176:285–290PubMedCrossRef
27.
Zurück zum Zitat Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Paré PD (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. New Engl J Med 350:2645–2653PubMedCrossRef Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Paré PD (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. New Engl J Med 350:2645–2653PubMedCrossRef
28.
Zurück zum Zitat Curtis JL, Freeman CM, Hogg JC (2007) The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research. Proc Am Thorac Soc 4:512–521PubMedCrossRef Curtis JL, Freeman CM, Hogg JC (2007) The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research. Proc Am Thorac Soc 4:512–521PubMedCrossRef
29.
Zurück zum Zitat Murphy TF, Brauer AL, Eschberger K, Lobbins P, Grove L, Cai X, Sethi S (2008) Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177:853–860PubMedCrossRef Murphy TF, Brauer AL, Eschberger K, Lobbins P, Grove L, Cai X, Sethi S (2008) Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177:853–860PubMedCrossRef
30.
Zurück zum Zitat Sethi S, Sethi R, Eschberger K, Lobbins P, Cai X, Grant BJ, Murphy TF (2007) Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176:356–361PubMedCrossRef Sethi S, Sethi R, Eschberger K, Lobbins P, Cai X, Grant BJ, Murphy TF (2007) Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176:356–361PubMedCrossRef
31.
Zurück zum Zitat MacNee W (2008) Update in chronic obstructive pulmonary disease 2007. Am J Respir Crit Care Med 177:820–829PubMedCrossRef MacNee W (2008) Update in chronic obstructive pulmonary disease 2007. Am J Respir Crit Care Med 177:820–829PubMedCrossRef
32.
Zurück zum Zitat Hodge S, Hodge G, Jersmann H, Matthews G, Ahern J, Holmes M, Reynolds PN (2008) Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 178:139–148PubMedCrossRef Hodge S, Hodge G, Jersmann H, Matthews G, Ahern J, Holmes M, Reynolds PN (2008) Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 178:139–148PubMedCrossRef
33.
Zurück zum Zitat Crystal RG, Randall SH, Engelhardt JF, Voynow J, Sunday ME (2008) Airway epithelial cells—current concepts and challenges. Proc Am Thorac Soc 5:772–777PubMedCrossRef Crystal RG, Randall SH, Engelhardt JF, Voynow J, Sunday ME (2008) Airway epithelial cells—current concepts and challenges. Proc Am Thorac Soc 5:772–777PubMedCrossRef
34.
Zurück zum Zitat Ammous Z, Hackett NR, Butler MW, Raman T, Dolgalev I, O’Connor TP, Harvey BG, Crystal RG (2008) Variability in small airway epithelial gene expression among normal smokers. Chest 133:1344–1353PubMedCrossRef Ammous Z, Hackett NR, Butler MW, Raman T, Dolgalev I, O’Connor TP, Harvey BG, Crystal RG (2008) Variability in small airway epithelial gene expression among normal smokers. Chest 133:1344–1353PubMedCrossRef
35.
Zurück zum Zitat Hunninghake GW, Kawanami O, Ferrans VJ, Young RC Jr, Roberts WC, Crystal RG (1981) Characterization of inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease. Am Rev Respir Dis 123:407–412PubMed Hunninghake GW, Kawanami O, Ferrans VJ, Young RC Jr, Roberts WC, Crystal RG (1981) Characterization of inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease. Am Rev Respir Dis 123:407–412PubMed
36.
Zurück zum Zitat Crystal RG, Bitterman PR, Rennard SI, Hance AJ, Keogh BA (1984) Interstitial lung diseases of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 310:154–166, 235–244 Crystal RG, Bitterman PR, Rennard SI, Hance AJ, Keogh BA (1984) Interstitial lung diseases of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 310:154–166, 235–244
37.
Zurück zum Zitat Daniele RP, Elias JA, Epstein PE, Rossman MD (1985) Bronchoalveolar lavage: role in the pathogenesis, diagnosis, and management of interstitial lung disease. Ann Intern Med 102:93–108PubMed Daniele RP, Elias JA, Epstein PE, Rossman MD (1985) Bronchoalveolar lavage: role in the pathogenesis, diagnosis, and management of interstitial lung disease. Ann Intern Med 102:93–108PubMed
38.
Zurück zum Zitat Drent M, van Nierop MA, Gerritsen FA, Wouters EF, Mulder PG (1996) A computer program using BALF-analysis results as a diagnostic tool in interstitial lung diseases. Am J Respir Crit Care Med 153:736–741PubMed Drent M, van Nierop MA, Gerritsen FA, Wouters EF, Mulder PG (1996) A computer program using BALF-analysis results as a diagnostic tool in interstitial lung diseases. Am J Respir Crit Care Med 153:736–741PubMed
39.
Zurück zum Zitat Reynolds HY (2009) Present status of bronchoalveolar lavage in interstitial lung disease. Curr Opin Pulm Dis 15:479–485CrossRef Reynolds HY (2009) Present status of bronchoalveolar lavage in interstitial lung disease. Curr Opin Pulm Dis 15:479–485CrossRef
40.
41.
Zurück zum Zitat Kinder BW, Shariat C, Collard HR, Koth LL, Wolters PJ, Golden JA, Panos RJ, King TE Jr (2010) Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function. Lung 188:143–149PubMedCrossRef Kinder BW, Shariat C, Collard HR, Koth LL, Wolters PJ, Golden JA, Panos RJ, King TE Jr (2010) Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function. Lung 188:143–149PubMedCrossRef
42.
Zurück zum Zitat Reynolds HY (1998) Diagnostic and management strategies for diffuse interstitial lung disease. Chest 113:192–202PubMedCrossRef Reynolds HY (1998) Diagnostic and management strategies for diffuse interstitial lung disease. Chest 113:192–202PubMedCrossRef
43.
Zurück zum Zitat Antin-Ozerkis D, Rubinowitz A (2008) Recognizing lung disease in patients with rheumatoid arthritis. Part 1: pleuropulmonary disease may be more common than you thought. J Respir Dis 29:274–280 Antin-Ozerkis D, Rubinowitz A (2008) Recognizing lung disease in patients with rheumatoid arthritis. Part 1: pleuropulmonary disease may be more common than you thought. J Respir Dis 29:274–280
44.
Zurück zum Zitat Antin-Ozerkis D, Rubinowitz A (2008) Recognizing lung disease in patients with rheumatoid arthritis. Part 2. J Respir Dis 29:318–324 Antin-Ozerkis D, Rubinowitz A (2008) Recognizing lung disease in patients with rheumatoid arthritis. Part 2. J Respir Dis 29:318–324
45.
Zurück zum Zitat Tashkin DP, Elashoff R, Clements PJ, Golden J, Roth MD, Furst DE, Arriola E, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Scleroderma Lung Study Research Group (2006) Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 354:2655–2666PubMedCrossRef Tashkin DP, Elashoff R, Clements PJ, Golden J, Roth MD, Furst DE, Arriola E, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Scleroderma Lung Study Research Group (2006) Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 354:2655–2666PubMedCrossRef
46.
Zurück zum Zitat Strange C, Bolster MB, Roth MD, Silver RM, Theodore A, Goldin J, Clements P, Chung J, Elashoff RM, Suh R, Smith EA, Furst DE, Tashkin DP, Scleroderma Lung Study Reserch Group (2008) Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease. Am J Respir Crit Care Med 177:91–98PubMedCrossRef Strange C, Bolster MB, Roth MD, Silver RM, Theodore A, Goldin J, Clements P, Chung J, Elashoff RM, Suh R, Smith EA, Furst DE, Tashkin DP, Scleroderma Lung Study Reserch Group (2008) Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease. Am J Respir Crit Care Med 177:91–98PubMedCrossRef
47.
Zurück zum Zitat Nagai S, Handa T, Ito Y, Takeuchi M, Izumi T (2007) Bronchoalveolar lavage in idiopathic interstitial lung diseases. Semin Respir Crit Care Med 28:496–503PubMedCrossRef Nagai S, Handa T, Ito Y, Takeuchi M, Izumi T (2007) Bronchoalveolar lavage in idiopathic interstitial lung diseases. Semin Respir Crit Care Med 28:496–503PubMedCrossRef
48.
Zurück zum Zitat Wang Y, Kuan PJ, Xing C, Cronkhite JT, Torres F, Rosenblatt RL, DiMaio JM, Kinch LN, Grishin NV, Garcia CK (2009) Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am J Hum Genet 84:52–59PubMedCrossRef Wang Y, Kuan PJ, Xing C, Cronkhite JT, Torres F, Rosenblatt RL, DiMaio JM, Kinch LN, Grishin NV, Garcia CK (2009) Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am J Hum Genet 84:52–59PubMedCrossRef
49.
Zurück zum Zitat Rosas IO, Richards TJ, Konishi K, Zhang Y, Gibson K, Lokshin AE, Lindell KO, Cisneros J, Macdonald SD, Pardo A, Sciurba F, Dauber J, Selman M, Gochuico BR, Kaminski N (2008) MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med 5:623–633CrossRef Rosas IO, Richards TJ, Konishi K, Zhang Y, Gibson K, Lokshin AE, Lindell KO, Cisneros J, Macdonald SD, Pardo A, Sciurba F, Dauber J, Selman M, Gochuico BR, Kaminski N (2008) MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med 5:623–633CrossRef
50.
Zurück zum Zitat Vasakova M, Sterclova M, Kolesart L, Slavcev A, Pohunek P, Sulc J, Skibova J, Striz I (2009) Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases. Scand J Immunol 69:268–274PubMedCrossRef Vasakova M, Sterclova M, Kolesart L, Slavcev A, Pohunek P, Sulc J, Skibova J, Striz I (2009) Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases. Scand J Immunol 69:268–274PubMedCrossRef
51.
Zurück zum Zitat Shinoda H, Tasaka S, Fujishima S, Yamasawa W, Miyamoto K, Nakano Y, Kamata H, Hasegawa N, Ishizaka A (2009) Elevated CC chemokine levels in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis. Respiration 78:285–292PubMedCrossRef Shinoda H, Tasaka S, Fujishima S, Yamasawa W, Miyamoto K, Nakano Y, Kamata H, Hasegawa N, Ishizaka A (2009) Elevated CC chemokine levels in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis. Respiration 78:285–292PubMedCrossRef
52.
Zurück zum Zitat Ohshimo S, Bonella F, Cui A, Beume M, Kohno N, Guzman J, Costabel U (2009) Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179:1043–1047PubMedCrossRef Ohshimo S, Bonella F, Cui A, Beume M, Kohno N, Guzman J, Costabel U (2009) Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179:1043–1047PubMedCrossRef
53.
Zurück zum Zitat Kawabata Y, Takermura T, Hebisawa A, Ogura T, Yamaguchi T, Kuriyama T, Nagai S, Sakatani M, Chida K, Sakai F, Park J, Colby TV (2008) Eosinophilia in bronchoalveolar lavage fluid and architectural destruction are features of desquamative interstitial pneumonia. Histopathology 52:194–202PubMedCrossRef Kawabata Y, Takermura T, Hebisawa A, Ogura T, Yamaguchi T, Kuriyama T, Nagai S, Sakatani M, Chida K, Sakai F, Park J, Colby TV (2008) Eosinophilia in bronchoalveolar lavage fluid and architectural destruction are features of desquamative interstitial pneumonia. Histopathology 52:194–202PubMedCrossRef
54.
Zurück zum Zitat Reynolds HY (2008) Respiratory structure and function: mechanisms and testing. In: Goldman L, Ausiello D (eds) Cecil medicine, 23rd edn. Saunders Elsevier, Philadelphia, pp 602–609 Reynolds HY (2008) Respiratory structure and function: mechanisms and testing. In: Goldman L, Ausiello D (eds) Cecil medicine, 23rd edn. Saunders Elsevier, Philadelphia, pp 602–609
55.
Zurück zum Zitat Reynolds HY, Fulmer JD, Kazmierowski JA, Roberts WC, Frank MM, Crystal RG (1977) Analysis of cellular and protein content of bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest 59:165–175PubMedCrossRef Reynolds HY, Fulmer JD, Kazmierowski JA, Roberts WC, Frank MM, Crystal RG (1977) Analysis of cellular and protein content of bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest 59:165–175PubMedCrossRef
56.
Zurück zum Zitat Drake WP, Newman LS (2006) Mycobacterial antigens may be important in sarcoidosis pathogenesis. Curr Opin Pulm Med 12:359–363PubMedCrossRef Drake WP, Newman LS (2006) Mycobacterial antigens may be important in sarcoidosis pathogenesis. Curr Opin Pulm Med 12:359–363PubMedCrossRef
58.
Zurück zum Zitat Reynolds HY (2002) Sarcoidosis: impact of other illness on the presentation and management of multiorgan disease. Lung 180:281–299PubMedCrossRef Reynolds HY (2002) Sarcoidosis: impact of other illness on the presentation and management of multiorgan disease. Lung 180:281–299PubMedCrossRef
59.
Zurück zum Zitat Grunewald J, Eklund A (2009) Löfgren’s syndrome: human leukocyte antigen strongly influences the disease course. Am J Respir Crit Care Med 179:301–312 Grunewald J, Eklund A (2009) Löfgren’s syndrome: human leukocyte antigen strongly influences the disease course. Am J Respir Crit Care Med 179:301–312
60.
Zurück zum Zitat Reynolds HY, Peavy HH, Gail DB, Kiley JP (2006) Review: past achievements and future directions of sarcoidosis research: a NHLBI perspective. Sarcoidosis Vasc Diffuse Lung Dis 23:83–91PubMed Reynolds HY, Peavy HH, Gail DB, Kiley JP (2006) Review: past achievements and future directions of sarcoidosis research: a NHLBI perspective. Sarcoidosis Vasc Diffuse Lung Dis 23:83–91PubMed
61.
Zurück zum Zitat Drent M, Mansour K, Linssen C (2007) Bronchoalveolar lavage in sarcoidosis. Semin Respir Crit Care Med 28:486–495PubMedCrossRef Drent M, Mansour K, Linssen C (2007) Bronchoalveolar lavage in sarcoidosis. Semin Respir Crit Care Med 28:486–495PubMedCrossRef
62.
Zurück zum Zitat Culver DA, Barna BP, Raychaudhuri B, Bonifield TL, Abraham S, Malur A, Farver CF, Kavuru MS, Thomassen MJ (2004) Peroxisome proliferator-activated receptor-gamma activity is deficient in alveolar macrophages in pulmonary sarcoidosis. Am J Respir Cell Mol Biol 30:1–5PubMedCrossRef Culver DA, Barna BP, Raychaudhuri B, Bonifield TL, Abraham S, Malur A, Farver CF, Kavuru MS, Thomassen MJ (2004) Peroxisome proliferator-activated receptor-gamma activity is deficient in alveolar macrophages in pulmonary sarcoidosis. Am J Respir Cell Mol Biol 30:1–5PubMedCrossRef
63.
Zurück zum Zitat Hart CM, Roman J, Reddy R, Sime PJ (2008) PPARγ: a novel molecular target in lung disease. J Invest Med 56:515–517 Hart CM, Roman J, Reddy R, Sime PJ (2008) PPARγ: a novel molecular target in lung disease. J Invest Med 56:515–517
64.
Zurück zum Zitat Bonfield TL, Farver CF, Barna BP, Malur A, Abraham S, Raychaudhuri B, Kavuru MS, Thomassen MJ (2003) Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis. Am J Respir Cell Mol Biol 29:677–682PubMedCrossRef Bonfield TL, Farver CF, Barna BP, Malur A, Abraham S, Raychaudhuri B, Kavuru MS, Thomassen MJ (2003) Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis. Am J Respir Cell Mol Biol 29:677–682PubMedCrossRef
65.
Zurück zum Zitat Ichikawa H, Kataoka M, Hiramatsu J, Ohmori M, Tanimoto Y, Kanehiro A, Nakata Y, Tanimoto M (2008) Quantitative analysis of propionibacterial DNA in bronchoalveolar lavage cells from patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 25:15–20PubMed Ichikawa H, Kataoka M, Hiramatsu J, Ohmori M, Tanimoto Y, Kanehiro A, Nakata Y, Tanimoto M (2008) Quantitative analysis of propionibacterial DNA in bronchoalveolar lavage cells from patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 25:15–20PubMed
66.
Zurück zum Zitat Danila E, Norkūniene J, Jurgauskiene L, Malickaite R (2009) Diagnostic role of BAL fluid CD4/CD8 ratio in different radiographic and clinical forms of pulmonary sarcoidosis. Clin Respir J 3:214–221 Danila E, Norkūniene J, Jurgauskiene L, Malickaite R (2009) Diagnostic role of BAL fluid CD4/CD8 ratio in different radiographic and clinical forms of pulmonary sarcoidosis. Clin Respir J 3:214–221
67.
Zurück zum Zitat Piotrowski WJ, Kurmanowska Z, Antczak A, Marczak J, Ciebiada M, Górski P (2010) Exhaled 8-isoprostane in sarcoidosis: relation to superoxide anion production by bronchoalveolar lavage cells. Inflamm Res 59:1027–1032PubMedCrossRef Piotrowski WJ, Kurmanowska Z, Antczak A, Marczak J, Ciebiada M, Górski P (2010) Exhaled 8-isoprostane in sarcoidosis: relation to superoxide anion production by bronchoalveolar lavage cells. Inflamm Res 59:1027–1032PubMedCrossRef
68.
Zurück zum Zitat Lockstone HE, Sanderson S, Kulakova N, Baban D, Leonard A, Kok WL, McGowan S, McMichael AJ, Ho LP (2010) Gene set analysis of lung samples provides insight into pathogenesis of progressive, fibrotic pulomonary sarcoidosis. Am J Respir Crit Care Med 181(12):1367–1375PubMedCrossRef Lockstone HE, Sanderson S, Kulakova N, Baban D, Leonard A, Kok WL, McGowan S, McMichael AJ, Ho LP (2010) Gene set analysis of lung samples provides insight into pathogenesis of progressive, fibrotic pulomonary sarcoidosis. Am J Respir Crit Care Med 181(12):1367–1375PubMedCrossRef
69.
Zurück zum Zitat Cordeiro CR, Jones JC, Alfaro T, Ferreina AJ (2007) Bronchoalveolar lavage in occupational lung diseases. Semin Respir Crit Care Med 28:504–513PubMedCrossRef Cordeiro CR, Jones JC, Alfaro T, Ferreina AJ (2007) Bronchoalveolar lavage in occupational lung diseases. Semin Respir Crit Care Med 28:504–513PubMedCrossRef
70.
Zurück zum Zitat Selman M, Lacasse Y, Pardo A, Cormier Y (2010) Hypersensitivity pneumonitis caused by fungi. Proc Am Thorac Soc 7:229–236PubMedCrossRef Selman M, Lacasse Y, Pardo A, Cormier Y (2010) Hypersensitivity pneumonitis caused by fungi. Proc Am Thorac Soc 7:229–236PubMedCrossRef
71.
Zurück zum Zitat Reynolds HY (1988) Hypersensitivity pneumonitis: correlation of cellular and immunologic changes with clinical phases of disease. Lung 166:189–208PubMedCrossRef Reynolds HY (1988) Hypersensitivity pneumonitis: correlation of cellular and immunologic changes with clinical phases of disease. Lung 166:189–208PubMedCrossRef
72.
Zurück zum Zitat Fink JN, Ortega HG, Reynolds HY, Cormier Y, Fan LL, Franks TJ, Kreiss K, Kunkel S, Lynch D, Quirce S, Rose C, Schleimer RP, Schuyler MR, Selman M, Trout D, Yoshizawa Y (2005) NHLBI workshop: needs and opportunities for research in hypersensitivity pneumonitis. Am J Respir Crit Care Med 171:792–798PubMedCrossRef Fink JN, Ortega HG, Reynolds HY, Cormier Y, Fan LL, Franks TJ, Kreiss K, Kunkel S, Lynch D, Quirce S, Rose C, Schleimer RP, Schuyler MR, Selman M, Trout D, Yoshizawa Y (2005) NHLBI workshop: needs and opportunities for research in hypersensitivity pneumonitis. Am J Respir Crit Care Med 171:792–798PubMedCrossRef
73.
Zurück zum Zitat Lacasse Y, Selman M, Costabel U, Dalphin JC, Morell F, Erkinjuntti-Pekkanen R, Mueller NL, Colby TV, Schuyler M, Jomphe V, Cormier Y, Study Group HP (2009) Classification of hypersensitivity pneumonitis: a hypothesis. Int Arch Allergy Immunol 149:161–166PubMedCrossRef Lacasse Y, Selman M, Costabel U, Dalphin JC, Morell F, Erkinjuntti-Pekkanen R, Mueller NL, Colby TV, Schuyler M, Jomphe V, Cormier Y, Study Group HP (2009) Classification of hypersensitivity pneumonitis: a hypothesis. Int Arch Allergy Immunol 149:161–166PubMedCrossRef
74.
Zurück zum Zitat Morell F, Roger A, Reyes L, Cruz MJ, Murio C, Muñoz X (2008) Bird fancier’s lung: a series of 86 patients. Medicine 87:110–130PubMedCrossRef Morell F, Roger A, Reyes L, Cruz MJ, Murio C, Muñoz X (2008) Bird fancier’s lung: a series of 86 patients. Medicine 87:110–130PubMedCrossRef
75.
Zurück zum Zitat Costabel U, Guzman J, Bonella F, Oshimo S (2007) Bronchoalveolar lavage in other interstitial lung diseases. Semin Respir Crit Care Med 28:514–524PubMedCrossRef Costabel U, Guzman J, Bonella F, Oshimo S (2007) Bronchoalveolar lavage in other interstitial lung diseases. Semin Respir Crit Care Med 28:514–524PubMedCrossRef
76.
Zurück zum Zitat Majori M, Poletti V, Curti A, Corradi M, Falcone F, Pesci A (2000) Bronchoalveolar lavage in bronchiolitis obliterans organizing pneumonia primed by radiation therapy to the breast. J Allergy Clin Immunol 105:239–244PubMedCrossRef Majori M, Poletti V, Curti A, Corradi M, Falcone F, Pesci A (2000) Bronchoalveolar lavage in bronchiolitis obliterans organizing pneumonia primed by radiation therapy to the breast. J Allergy Clin Immunol 105:239–244PubMedCrossRef
77.
Zurück zum Zitat Poletti V, Poletti G, Murer B, Saragoni L, Chilosi M (2007) Bronchoalveolar lavage in malignancy. Semin Respir Crit Care Med 28:534–545PubMedCrossRef Poletti V, Poletti G, Murer B, Saragoni L, Chilosi M (2007) Bronchoalveolar lavage in malignancy. Semin Respir Crit Care Med 28:534–545PubMedCrossRef
78.
Zurück zum Zitat Borczuk AC, Toonkel RL, Powell CA (2009) Genomics of lung cancer. Proc Am Thorac Soc 6:152–158PubMedCrossRef Borczuk AC, Toonkel RL, Powell CA (2009) Genomics of lung cancer. Proc Am Thorac Soc 6:152–158PubMedCrossRef
79.
Zurück zum Zitat Wilkes DS, Egan TM, Reynolds HY (2005) NHLBI Workshop: lung transplantation—opportunities for research and clinical advancement. Am J Respir Crit Care Med 172:944–955PubMedCrossRef Wilkes DS, Egan TM, Reynolds HY (2005) NHLBI Workshop: lung transplantation—opportunities for research and clinical advancement. Am J Respir Crit Care Med 172:944–955PubMedCrossRef
80.
81.
Zurück zum Zitat Iacono AT, Johnson BA, Grgurich WF, Youssef JG, Corcoran TE, Seiler DA, Dauber JH, Smaldone GC, Zeevi A, Yousem SA, Fung JJ, Burckart GJ, McCurry KR, Griffith BP (2006) A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med 354:141–150PubMedCrossRef Iacono AT, Johnson BA, Grgurich WF, Youssef JG, Corcoran TE, Seiler DA, Dauber JH, Smaldone GC, Zeevi A, Yousem SA, Fung JJ, Burckart GJ, McCurry KR, Griffith BP (2006) A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med 354:141–150PubMedCrossRef
82.
Zurück zum Zitat Belperio JA, Weigt SS, Fishbein MC, Lynch JP III (2009) Chronic lung allograft rejection: mechanisms and therapy. Proc Am Thorac Soc 6:108–121PubMedCrossRef Belperio JA, Weigt SS, Fishbein MC, Lynch JP III (2009) Chronic lung allograft rejection: mechanisms and therapy. Proc Am Thorac Soc 6:108–121PubMedCrossRef
83.
Zurück zum Zitat Muylem AV, Knoop C, Estenne M (2007) Early detection of chronic pulmonary allograft dysfunction by exhaled biomarkers. Am J Respir Crit Care Med 175:731–736PubMedCrossRef Muylem AV, Knoop C, Estenne M (2007) Early detection of chronic pulmonary allograft dysfunction by exhaled biomarkers. Am J Respir Crit Care Med 175:731–736PubMedCrossRef
84.
Zurück zum Zitat Christie JD, Shah CV, Kawut SM, Mangalmurti N, Lederer DJ, Sonett JR, Ahya VN, Palmer SM, Wille K, Lama V, Shah PD, Shah A, Weinacker A, Deutschman CS, Kohl BA, Demissie E, Bellamy S, Ware LB, Lung Transplant Outcomes Group (2009) Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. Am J Respir Crit Care Med 180:1010–1015PubMedCrossRef Christie JD, Shah CV, Kawut SM, Mangalmurti N, Lederer DJ, Sonett JR, Ahya VN, Palmer SM, Wille K, Lama V, Shah PD, Shah A, Weinacker A, Deutschman CS, Kohl BA, Demissie E, Bellamy S, Ware LB, Lung Transplant Outcomes Group (2009) Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. Am J Respir Crit Care Med 180:1010–1015PubMedCrossRef
85.
Zurück zum Zitat Wilkes DS (2009) Primary graft dysfunction: it’s all the RAGE (editorial). Am J Respir Crit Care Med 180:915–919PubMedCrossRef Wilkes DS (2009) Primary graft dysfunction: it’s all the RAGE (editorial). Am J Respir Crit Care Med 180:915–919PubMedCrossRef
86.
Zurück zum Zitat Avila M, Ojcius DM, Yilmaz Ö (2009) The oral microbiota: living with a permanent guest. DNA Cell Biol 25:405–411CrossRef Avila M, Ojcius DM, Yilmaz Ö (2009) The oral microbiota: living with a permanent guest. DNA Cell Biol 25:405–411CrossRef
87.
Zurück zum Zitat Young KR Jr, Rankin JA, Naegel GP, Paul ES, Reynolds HY (1985) Bronchoalveolar lavage cells and proteins in patients with the acquired immunodeficiency syndrome. Ann Intern Med 103:522–533PubMed Young KR Jr, Rankin JA, Naegel GP, Paul ES, Reynolds HY (1985) Bronchoalveolar lavage cells and proteins in patients with the acquired immunodeficiency syndrome. Ann Intern Med 103:522–533PubMed
88.
Zurück zum Zitat Jafari C, Thijsen S, Sotgiu G, Goletti D, Benítez JA, Losi M, Eberhardt R, Kirsten D, Kalsdorf B, Bossink A, Latorre I, Migliori GB, Strassburg A, Winteroll S, Greinert U, Richeldi L, Ernst M, Lange C, Tuberculosis Network European Trialsgroup (2009) Bronchoalveolar lavage enzyme-linked immunospot for rapid diagnosis of tuberculosis (A Tuberculosis Network European Trials Group Study). Am J Respir Crit Care Med 180:666–673PubMedCrossRef Jafari C, Thijsen S, Sotgiu G, Goletti D, Benítez JA, Losi M, Eberhardt R, Kirsten D, Kalsdorf B, Bossink A, Latorre I, Migliori GB, Strassburg A, Winteroll S, Greinert U, Richeldi L, Ernst M, Lange C, Tuberculosis Network European Trialsgroup (2009) Bronchoalveolar lavage enzyme-linked immunospot for rapid diagnosis of tuberculosis (A Tuberculosis Network European Trials Group Study). Am J Respir Crit Care Med 180:666–673PubMedCrossRef
89.
Zurück zum Zitat Tunney MM, Field TR, Moriarty TF, Patrick S, Doering G, Muhlebach MS, Wolfgang MC, Boucher R, Gilpin DF, McDowell A, Elborn JS (2008) Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 177:995–1001PubMedCrossRef Tunney MM, Field TR, Moriarty TF, Patrick S, Doering G, Muhlebach MS, Wolfgang MC, Boucher R, Gilpin DF, McDowell A, Elborn JS (2008) Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 177:995–1001PubMedCrossRef
90.
Zurück zum Zitat Fasano MB (2010) Combined airway: impact of upper airway on lower airway. Curr Opin Otolaryngol Head Neck Surg 18:15–20PubMedCrossRef Fasano MB (2010) Combined airway: impact of upper airway on lower airway. Curr Opin Otolaryngol Head Neck Surg 18:15–20PubMedCrossRef
91.
Zurück zum Zitat Boujaoude ZC, Bartter TC, Pratter MR, Fasano MB (2008) Tips on the management of rhinosinusitis. J Respir Dis 29:353–359 Boujaoude ZC, Bartter TC, Pratter MR, Fasano MB (2008) Tips on the management of rhinosinusitis. J Respir Dis 29:353–359
92.
Zurück zum Zitat Mahesh PA, Vedanthan PK, Holla AD (2009) Time interval and the factors associated with the development of asthma in patients with allergic rhinitis. Lung 187:393–400PubMedCrossRef Mahesh PA, Vedanthan PK, Holla AD (2009) Time interval and the factors associated with the development of asthma in patients with allergic rhinitis. Lung 187:393–400PubMedCrossRef
93.
Zurück zum Zitat Schleimer RP, Kato A, Peters A, Conley D, Kim J, Liu MC, Harris KE, Kuperman DA, Chandra R, Favoreto S Jr, Avila PC, Grammer LC, Kern RC (2009) Epithelium, inflammation, and immunity in the upper airways of humans. Proc Am Thorac Soc 6:288–294PubMedCrossRef Schleimer RP, Kato A, Peters A, Conley D, Kim J, Liu MC, Harris KE, Kuperman DA, Chandra R, Favoreto S Jr, Avila PC, Grammer LC, Kern RC (2009) Epithelium, inflammation, and immunity in the upper airways of humans. Proc Am Thorac Soc 6:288–294PubMedCrossRef
94.
Zurück zum Zitat Ciarleglio G, Refini RM, Pieroni MG, Martino VA, Bargagli E, Rottoli P, Sestini P (2008) Exhaled carbon monoxide in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 25:46–50PubMed Ciarleglio G, Refini RM, Pieroni MG, Martino VA, Bargagli E, Rottoli P, Sestini P (2008) Exhaled carbon monoxide in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 25:46–50PubMed
95.
Zurück zum Zitat Corradi M, Pignatti P, Brunetti G, Goldoni M, Caglieri A, Nava S, Moscato G, Balbi B (2008) Comparison between exhaled and bronchoalveolar lavage levels of hydrogen peroxide in patients with diffuse interstitial lung diseases. ACTA Biomed 79(suppl):73–78PubMed Corradi M, Pignatti P, Brunetti G, Goldoni M, Caglieri A, Nava S, Moscato G, Balbi B (2008) Comparison between exhaled and bronchoalveolar lavage levels of hydrogen peroxide in patients with diffuse interstitial lung diseases. ACTA Biomed 79(suppl):73–78PubMed
96.
Zurück zum Zitat Pérez-de-Llano LA, Carballada F, Castro Añón O, Pizarro M, Golpe R, Baloira A, Vázquez Caruncho M, Boquete M (2010) Exhaled nitric oxide predicts controls in patients with difficult-to-treat asthma. Eur Respir J 35(6):1221–1227PubMedCrossRef Pérez-de-Llano LA, Carballada F, Castro Añón O, Pizarro M, Golpe R, Baloira A, Vázquez Caruncho M, Boquete M (2010) Exhaled nitric oxide predicts controls in patients with difficult-to-treat asthma. Eur Respir J 35(6):1221–1227PubMedCrossRef
97.
Zurück zum Zitat Esther CR Jr, Boysen G, Olsen BM, Collins LB, Ghio AJ, Swenberg JW, Boucher RC (2009) Mass spectrometric analysis of biomarkers and dilution markers in exhaled breath condensate reveals elevated purines in asthma and cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 296:L987–L993PubMedCrossRef Esther CR Jr, Boysen G, Olsen BM, Collins LB, Ghio AJ, Swenberg JW, Boucher RC (2009) Mass spectrometric analysis of biomarkers and dilution markers in exhaled breath condensate reveals elevated purines in asthma and cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 296:L987–L993PubMedCrossRef
98.
Zurück zum Zitat Fens N, Zwinderman AH, Van der Schee MP, de Nijs SB, Dijkers E, Roldaan AC, Cheung D, Bel EH, Sterk PJ (2009) Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 180:1076–1082PubMedCrossRef Fens N, Zwinderman AH, Van der Schee MP, de Nijs SB, Dijkers E, Roldaan AC, Cheung D, Bel EH, Sterk PJ (2009) Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 180:1076–1082PubMedCrossRef
99.
Zurück zum Zitat Machado RF (2009) Identifying chronic obstructive pulmonary disease and asthma by exhaled breath analysis (editorial). Am J Respir Crit Care Med 180:1038–1039PubMedCrossRef Machado RF (2009) Identifying chronic obstructive pulmonary disease and asthma by exhaled breath analysis (editorial). Am J Respir Crit Care Med 180:1038–1039PubMedCrossRef
100.
101.
Zurück zum Zitat Barnes PJ, Dweik RA, Gelb AF, Gibson PG, George SC, Grasemann H, Pavord ID, Ratjen F, Silkoff PE, Taylor DR, Zamel N (2010) Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest 138:682–692PubMedCrossRef Barnes PJ, Dweik RA, Gelb AF, Gibson PG, George SC, Grasemann H, Pavord ID, Ratjen F, Silkoff PE, Taylor DR, Zamel N (2010) Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest 138:682–692PubMedCrossRef
102.
Zurück zum Zitat Lázár Z, Cervenak L, Orosz M, Gálffy G, Komlósi ZI, Bikov A, Losonczy G, Horváth I (2010) Adenosine triphosphate concentration of exhaled breath condensate in asthma. Chest 138:536–542PubMedCrossRef Lázár Z, Cervenak L, Orosz M, Gálffy G, Komlósi ZI, Bikov A, Losonczy G, Horváth I (2010) Adenosine triphosphate concentration of exhaled breath condensate in asthma. Chest 138:536–542PubMedCrossRef
103.
Zurück zum Zitat Lin JL, Bonnichsen MH, Nogeh EU, Raftery MJ, Thomas PS (2010) Proteomics in detection and monitoring of asthma and smoking-related lung diseases. Expert Rev Proteomics 7(3):361–372PubMedCrossRef Lin JL, Bonnichsen MH, Nogeh EU, Raftery MJ, Thomas PS (2010) Proteomics in detection and monitoring of asthma and smoking-related lung diseases. Expert Rev Proteomics 7(3):361–372PubMedCrossRef
104.
Zurück zum Zitat Reynolds HY, Chrétien J (1984) Respiratory tract fluids: analysis of content and contemporary use in understanding lung diseases. Dis Mon 30(5):3–103 Reynolds HY, Chrétien J (1984) Respiratory tract fluids: analysis of content and contemporary use in understanding lung diseases. Dis Mon 30(5):3–103
105.
Zurück zum Zitat Reynolds HY, Merrill WW (1981) Airway changes in young smokers that may antedate chronic obstructive lung disease. Med Clin North Am 65:667–689PubMed Reynolds HY, Merrill WW (1981) Airway changes in young smokers that may antedate chronic obstructive lung disease. Med Clin North Am 65:667–689PubMed
106.
107.
Zurück zum Zitat Franks TJ, Colby TV, Travis WD, Tuder RM, Reynolds HY, Brody AR, Cardoso WV, Crystal RG, Drake CJ, Engelhardt J, Frid M, Herzog E, Mason R, Phan SH, Randell SH, Rose MC, Stevens T, Serge J, Sunday ME, Voynow JA, Weinstein BM, Whitsett J, Williams MC (2008) Resident cellular components of the human lung: current knowledge and goals for research on cell phenotyping and function. Proc Am Thorac Soc 5:763–766PubMedCrossRef Franks TJ, Colby TV, Travis WD, Tuder RM, Reynolds HY, Brody AR, Cardoso WV, Crystal RG, Drake CJ, Engelhardt J, Frid M, Herzog E, Mason R, Phan SH, Randell SH, Rose MC, Stevens T, Serge J, Sunday ME, Voynow JA, Weinstein BM, Whitsett J, Williams MC (2008) Resident cellular components of the human lung: current knowledge and goals for research on cell phenotyping and function. Proc Am Thorac Soc 5:763–766PubMedCrossRef
108.
Zurück zum Zitat Guo YL, Chen YQ, Wang K, Qin SM, Wu C, Kong JL (2010) Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systemic review. Chest 138:817–824PubMedCrossRef Guo YL, Chen YQ, Wang K, Qin SM, Wu C, Kong JL (2010) Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systemic review. Chest 138:817–824PubMedCrossRef
109.
Zurück zum Zitat Jayaraman S, Gayathri AR, Kumar PS, Santosham R, Santosham R, Narasimhan R (2010) Whole lung lavage for pulmonary alveolar proteinosis. Lung India 27:33–36PubMedCrossRef Jayaraman S, Gayathri AR, Kumar PS, Santosham R, Santosham R, Narasimhan R (2010) Whole lung lavage for pulmonary alveolar proteinosis. Lung India 27:33–36PubMedCrossRef
Metadaten
Titel
Bronchoalveolar Lavage and Other Methods to Define the Human Respiratory Tract Milieu in Health and Disease
verfasst von
Herbert Y. Reynolds
Publikationsdatum
01.04.2011
Verlag
Springer-Verlag
Erschienen in
Lung / Ausgabe 2/2011
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-011-9284-5

Weitere Artikel der Ausgabe 2/2011

Lung 2/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.